Aptevo Therapeutics Inc (NASDAQ:APVO) insider Marvin L. White sold 100,000 shares of the company’s stock in a transaction dated Monday, March 19th. The shares were sold at an average price of $2.93, for a total transaction of $293,000.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
APVO stock traded up $0.12 on Wednesday, reaching $2.98. 43,601 shares of the company’s stock traded hands, compared to its average volume of 179,009. The company has a current ratio of 5.14, a quick ratio of 5.08 and a debt-to-equity ratio of 0.19. Aptevo Therapeutics Inc has a 1-year low of $1.15 and a 1-year high of $4.85.
A number of institutional investors and hedge funds have recently bought and sold shares of APVO. Acadian Asset Management LLC lifted its stake in Aptevo Therapeutics by 87.2% during the 4th quarter. Acadian Asset Management LLC now owns 67,799 shares of the biotechnology company’s stock valued at $287,000 after acquiring an additional 31,578 shares during the period. Virtu Financial LLC bought a new position in Aptevo Therapeutics during the 4th quarter valued at about $690,000. Victory Capital Management Inc. bought a new position in Aptevo Therapeutics during the 4th quarter valued at about $827,000. Renaissance Technologies LLC lifted its stake in Aptevo Therapeutics by 411.8% during the 4th quarter. Renaissance Technologies LLC now owns 428,400 shares of the biotechnology company’s stock valued at $1,816,000 after acquiring an additional 344,700 shares during the period. Finally, Dimensional Fund Advisors LP lifted its stake in Aptevo Therapeutics by 8.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,056,729 shares of the biotechnology company’s stock valued at $2,187,000 after acquiring an additional 78,109 shares during the period. Institutional investors and hedge funds own 33.04% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Aptevo Therapeutics Inc (APVO) Insider Sells $293,000.00 in Stock” was published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright law. The correct version of this report can be accessed at https://www.thelincolnianonline.com/2018/03/21/aptevo-therapeutics-inc-apvo-insider-sells-293000-00-in-stock.html.
About Aptevo Therapeutics
Aptevo Therapeutics Inc is a biotechnology company. The Company is focused on oncology and hematology therapeutics. The Company is engaged in the discovery, development, commercialization and sale of oncology and hematology therapeutics. The Company’s technology is the ADAPTIR (modular protein technology) platform.
Receive News & Ratings for Aptevo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptevo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.